CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
ATLANTA, Aug. 4 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE: CRY ) an implantable biological medical device and cardiovascular tissue processing company, today announced it has received CE mark approval for its BioFoam((R)) Surgical Matrix (BioFoam). The CE mark allows immediate, unrest...Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration...Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
ALLEGAN, Mich., Aug. 3 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) (previously Barr Laboratories Inc.) has received final approval from the U.S. Food and Drug Administration ...FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
Panel Votes in Favor of Use by Physician/Nurse Teams to Deliver Minimal-to-Moderate Propofol Sedation CINCINNATI, May 28 /PRNewswire/ -- Ethicon Endo-Surgery today announced that the Anesthesiology and Respiratory Therapy Devices Advisory Committee of the U.S. Food and Drug Administration (FD...SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems
HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its involvement in Hologic's (formerly Third Wave Technologies) successful clinical trials of two Human Papillomavirus (HPV) in vitro diagnostic tests. SeqWright p...FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
PARIS, March 18 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that the Cardiovascular and Renal Drugs Advisory Committee voted 10 to 3 in favor of the approval of Multaq(R) by the U.S. Food and Drug Administration (FDA) to treat patients with non-perma...FDA Stem Cell Approval Breakthrough Laudable
SAN CLEMENTE, Calif., Jan. 23 /PRNewswire/ -- Today the FDA announced approval for the first clinical trials on humans using Embryonic Stem Cells but Adult Stem Cell scientist Christian Drapeau says the experts may not be telling the whole story; Adult Stem Cells have greater potential with le...AirLife On-board Oxygen Concentrator
Description:... in use today by several overseas airlines. With the US governments FAA/STC approval for this product to be installed on specific Boeing commercial aircraft, Ai...Concentrator, a non-hazmat (non hazardous material) product, is pending FAA approval to make it the first therapeutic oxygen device that would be permitted to b...AcrySof ReSTOR Apodized Diffractive IOL
Description:... The U.S. Food and Drug Administration (FDA) has granted approval of Alcon's AcrySof ReSTOR intraocular lens (IOL) for cataract patients with...ndependence from glasses after surgery. The clinical studies supporting the approval showed that 80 percent of patients who received the AcrySof ReSTOR lens did...Paragon Quadra RG 100 (paflufocon D)
Description:...freedom from glasses and daytime contacts without surgery. Paragon CRT sets the standard for Corneal Refractive Therapy not only with the first FDA approval for overnight CRT but also by offering a Total System which includes a Diagnostic Dispensing System and a Complete Practice Management Program. Wit...Paragon Quadra RG (paflufocon B)
Description:...freedom from glasses and daytime contacts without surgery. Paragon CRT sets the standard for Corneal Refractive Therapy not only with the first FDA approval for overnight CRT but also by offering a Total System which includes a Diagnostic Dispensing System and a Complete Practice Management Program. Wit...Extracorporeal shockwave therapy
... musculo-skeletal conditions. Presently it is only FDA approved for treatment of plantar heel spurs, plantar fasciitis and tennis elbow. In the future approval may be given to treat patella tendinitis, shoulder tendinitis, achilles tendinitis, pseudoarthrosis, stress fractures and shoulder calcification. Ther...French Authorities Give Sole Approval to GMAT Exam to Collect Biometric Data to Advance Security
MCLEAN, Va., July 9 /PRNewswire-USNewswire/ -- For the first time in its history, the French National Commission for Data Protection and the Liberties (CNIL) has granted approval to a private testing company -- the Graduate Management Admission Council (GMAC) -- to collect biometric data as part o...Hebrew University professor's work leads to FDA approval for product
Jerusalem, March 25, 2009 A material developed at the Hebrew University of Jerusalem that is designed to prevent adhesions (scar tissue) following surgery has led to approval by the U.S. Food and Drug Administration (FDA) of a product for use in pediatric cardiac surgery patients. The product...Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
"The report today that the FDA has approved the first human clinical trial of an embryonic stem cell-based intervention raises important ethical considerations, but not only, or even primarily, because what is at issue is an embryonic stem cell-based intervention. Although deep-seated disagreemen...New tool to speed cancer therapy approval available
PHILADELPHIA Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent. That means many research hours and dollars are wasted chasing avenues that will not br...The MDS foundation supports vidaza's recommendation for European approval
The Myelodysplastic Syndromes (MDS) Foundation supports the positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) recommending approval of VIDAZA (azacitidine) for specific types of MDS patients, including those with high-risk MDS, chronic myelomonocytic ...Exciton Technologies receives FDA approval to market exSALT(TM)
EDMONTON, Aug. 5 /PRNewswire/ - Exciton Technologies Inc. today announced that the Company has received approval from the United States Food and Drug Administration (FDA) to market exSALT(TM) SD7 Wound Dressing, a product incorporating Exciton's patented platform coating technology utilizing silve...Sunesis Receives Approval for Listing on The NASDAQ Capital Market
SOUTH SAN FRANCISCO, Calif., July 30 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced th...Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) today announced that its stockholders overwhelmingly approved the adoption of its merger agreement with Pfizer (NYSE: PFE ) at Wyeth's Annual Meeting of Stockholders. Based on a preliminary vote count by Wyeth's tra...Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
VANCOUVER, July 16 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX ) has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) ...Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
NATICK, Mass., July 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark for its LATITUDE(R) Patient Management system. The LATITUDE system remotely monitors patients with implantable cardiac devices, gathering information on both the device and...Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
PITTSBURGH, July 7 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bicalutamide Tablets, 50 mg. Bical...Agilent ChemStation Plus Networked Data Systems from Agilent Technologies
Description:...ree-dimensional data. Then, expand the systems power with add-on software modules. ChemStore Data Organization Module, for easy organization, review, approval and storage of your data. ChemAccess Remote Access Module, for remote control and status monitoring of instruments as well as file and peripheral sh...AAIBiotech Solutions from AAIPharma Inc.
Description:...in product development with special qualities of collaborative team chemistry. This combination enables optimum solutions and strategy from concept to approval and beyond. With AAIBiotech, you can count on our excellent scientific capabilities. But you get more than that: its the power of team chemistry ...